CIAM
EW icon

Caitong International Asset Management’s Edwards Lifesciences EW Stock Holding History

Caitong International Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$1.55K – 2037
2025
Q3 		$1.55K Buy
20
+13
+186% +$1.02K ﹤0.01% 1412
2025
Q2 		$547 Buy
+7
New +$522 ﹤0.01% 1685
2025
Q1 		– Sell
-167
Closed -$12.4K – 2272
2024
Q4 		$12.4K Buy
+167
New +$11.7K 0.01% 912

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caitong International Asset Management's EW Position: Q4 2025 in Review

Caitong International Asset Management sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 20 shares — an estimated $1.55K sold.

Caitong International Asset Management first reported a position in EW in Q4 2024 and held it in 3 quarters. The position peaked at $12.4K in Q4 2024. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Caitong International Asset Management reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 20 Edwards Lifesciences shares in Q4 2025, an estimated $1.55K.
  • Caitong International Asset Management first reported a position in Edwards Lifesciences in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Edwards Lifesciences position peaked at $12.4K in Q4 2024.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.